Stable medicine combination

A composition and drug technology, applied in the field of stable pharmaceutical compositions, can solve the problems of pharmaceutical compositions failing to meet the storage period requirements, restrictions on large-scale popularization and use, and difficult operation of formulated products, so as to achieve fast and rapid onset of effect Thoroughly absorbed, low-cost effect

CN101336920AActive Publication Date: 2009-01-07NANJING CHIA TAI TIANQING PHARMA
2 Cites 14 Cited by

Patent Information

Authority / Receiving Office
CN · China
Current Assignee / Owner
Publication Date
2009-01-07

Smart Images

  • Figure 1
    Figure 1
  • Figure 2
    Figure 2
Patent Text Reader

Abstract

The invention relates to a stable oral pharmaceutical composition, particularly to a pharmaceutical composition comprising rosuvastatin calcium, micropowder silica gel and pharmaceutically-acceptable adjuvants, and a preparation method and an application thereof.
Need to check novelty before this filing date? Find Prior Art

Description

technical field

[0001] The present invention relates to a stable pharmaceutical composition, in particular to rosuvastatin calcium: bis[(E)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[formazan A stable pharmaceutical composition of (methylsulfonyl)amino]pyrimidin-5-yl]-(3R,5S)-3,5-dihydroxyhept-6-enoic acid]calcium salt (as shown in formula I).

[0002]

[0003] Formula I Background technique

[0004] Rosuvastatin calcium is a potent 3-hydroxy-3-methylglutaryl coenzyme A reductase (HMGCoA reductase) inhibitor, which can be used in the treatment of hypercholesterolemia, hyperlipoproteinemia and atherosclerosis It is better than other statins on the market in reducing low-density lipoprotein (LDL-C) and increasing high-density lipoprotein (HDL-C), and it is well tolerated and safe. For "super statin".

[0005] One disadvantage of rosuvastatin calcium is that it is easily degraded under certain circumstances, such as in a higher temperature or higher humidity environment, and th...

Examples

Embodiment 1

[0028] Raw material name 1000 tablets dosage (g)

[0029] Rosuvastatin calcium 10.4 (equivalent to rosuvastatin 10g)

[0030] Micronized silica gel 6

[0031] Microcrystalline Cellulose 80

[0032] Lactose 95

[0033] Crospovidone (internal addition) 8

[0034] Crospovidone (additional) 8

[0035] Povidone K 30 5

[0036] Appropriate amount of water

[0037] Magnesium Stearate 2

[0038] Gastric-soluble film coating premix appropriate amount

[0039] Pass rosuvastatin calcium and micro-powder silica gel through a 100-mesh sieve and mix evenly, add the prescribed amount of microcrystalline cellulose, lactose, crospovidone (internal addition), and povidone through a 80-mesh sieve, and mix well . Add an appropriate amount of water-based soft material to the powder, pass through a 20-mesh sieve to granulate, blow dry at 45°C, pass the dry granules through a 20-mesh sieve for granulation, add the prescribed amount of crospovidone (additional), mix properly an...

Embodiment 2

[0041] Raw material name 1000 tablets dosage (g)

[0042] Rosuvastatin calcium 5.2 (equivalent to rosuvastatin 5g)

[0043] Micronized silica gel 5

[0044] Pregelatinized starch 60

[0045] Mannitol 75

[0046] Low-substituted hydroxypropyl cellulose 5

[0047] 3% hypromellose (E 5 ) aqueous solution appropriate amount

[0048] Magnesium Stearate 1

[0049] Gastric-soluble film coating premix appropriate amount

[0050] Pass rosuvastatin calcium and micropowder silica gel through a 100-mesh sieve and mix evenly, add pregelatinized starch, mannitol, and low-substituted hydroxypropyl cellulose in the prescribed amount and pass through an 80-mesh sieve, and mix well. Add an appropriate amount of 3% hydroxypropyl methylcellulose aqueous solution to the powder to make a soft material, pass through a 20-mesh sieve to granulate, dry at 45°C, dry the dry granules through a 20-mesh sieve, add the prescribed amount of magnesium stearate, well mixed. After detecting the interme...

Embodiment 3

[0052] Raw material name 1000 tablets dosage (g)

[0053] Rosuvastatin calcium 20.8 (equivalent to rosuvastatin 20g)

[0054] Micronized silica gel 10

[0055] Microcrystalline Cellulose 60

[0056] Cross-linked hydroxypropyl methylcellulose 9

[0057] Appropriate amount of water

[0058] Stearic acid 0.8

[0059] Gastric-soluble film coating premix appropriate amount

[0060] Pass rosuvastatin calcium and micropowder silica gel through a 100-mesh sieve and mix evenly, add the prescribed amount of microcrystalline cellulose and cross-linked hydroxypropyl methylcellulose that pass through an 80-mesh sieve, and mix well. Add an appropriate amount of water-based soft material to the powder, pass through a 24-mesh sieve to granulate, blow dry at 45°C, pass the dry granules through a 24-mesh sieve for granulation, add the prescribed amount of stearic acid passed through a 80-mesh sieve, and mix well. After detecting the intermediate content and water content, the tablet is pr...